Vancomycin

From IDWiki
Revision as of 17:58, 11 August 2019 by Maintenance script (talk | contribs) (Imported from text file)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Vancomycin

Indications

  • Suspected or confirmed MRSA

Dosing

  • Common dose
    • 15mg/kg/dose with timing based on renal function (q12h if normal)
    • Titrate based on serum trough drawn within hour before fourth dose
  • Target trough
    • 10-15 for low-risk infections
    • 15-20 for high-risk infections such as osteomyelitis, meningitis, and bacteremia

Adverse Reactions

Renal Failures

  • Risk factors
    • Prolonged courses >21 days
    • Higher trough
    • Concomitant nephrotoxic medication
    • Older age
    • CKD/AKI
    • Liver disease
    • Peritonitis
    • Neutropenia
    • Male sex
  • Mechanism of injury: oxidative stress in the proximal tubular cells

Red Man Syndrome

  • Rash, pruritis, and hypotension, with onset of vancomycin, resolves on stopping
  • Very high incidence previously
  • Histamine-mediated
  • Can decrease dose or prolong infusion, prophylactic antihistamines

References

  1. ^  Michael J Rybak, Jennifer Le, Thomas P Lodise, Donald P Levine, John S Bradley, Catherine Liu, Bruce A Mueller, Manjunath P Pai, Annie Wong-Beringer, John C Rotschafer, Keith A Rodvold, Holly D Maples, Benjamin M Lomaestro. Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. American Journal of Health-System Pharmacy. 2020. doi:10.1093/ajhp/zxaa036.